medigraphic.com
ENGLISH

Archivos de Neurociencias

Instituto Nacional de Neurología y Neurocirugía
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2022, Número 3

<< Anterior Siguiente >>

Arch Neurocien 2022; 27 (3)


Protective effects of Buxus hyrcana against memory impairment and oxidative stress in a pentylenetetrazole-kindled epileptic rat model

Azizi V, Allahyari F, Hosseini A
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 41
Paginas: 16-22
Archivo PDF: 205.12 Kb.


PALABRAS CLAVE

Sin palabras Clave

RESUMEN

Si resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Katyayan A, Diaz-Medina G. Epilepsy: Epileptic Syndromes andTreatment. Neurol Clin. 2021;39(3):779-795. doi:10.1016/j.ncl.2021.04.002

  2. Suleymanova EM. Behavioral comorbidities of epilepsy andneuroinflammation: Evidence from experimental and clinicalstudies. Epilepsy Behav. 2021; 117:107869. doi:10.1016/j.yebeh.2021.107869

  3. Fattorusso A, Matricardi S, Mencaroni E, et al. ThePharmacoresistant Epilepsy: An Overview on Existant andNew Emerging Therapies. Front Neurol. 2021; 12:674483.doi:10.3389/fneur.2021.674483

  4. Holmes GL. Cognitive impairment in epilepsy: the role ofnetwork abnormalities. Epileptic Disord. 2015; 17(2):101-116.doi:10.1684/epd.2015.0739

  5. Waldbaum S, Patel M. Mitochondria, oxidative stress, andtemporal lobe epilepsy. Epilepsy research. 2010; 88(1):23-45.

  6. Costello DJ, Delanty N. Oxidative injury in epilepsy: potential forantioxidant therapy? Expert Rev Neurother. 2004; 4(3):541-553.

  7. Stadtman ER. Protein oxidation in aging and age‐relateddiseases. Ann N Y Acad Sci. 2001; 928(1):22-38.

  8. Migliore L, Fontana I, Colognato R, Coppede F, SicilianoG, Murri L. Searching for the role and the most suitablebiomarkers of oxidative stress in Alzheimer's disease and inother neurodegenerative diseases. Neurobiol Aging. 2005;26(5):587-595.

  9. Bonda DJ, Lee H-P, Lee H-g, et al. Novel therapeutics forAlzheimer's disease: an update. Curr Opin Drug Discov Dev.2010; 13(2):235.

  10. Ashrafi MR, Shams S, Nouri M, et al. A probable causative factorfor an old problem: selenium and glutathione peroxidase appearto play important roles in epilepsy pathogenesis. Epilepsia.2007; 48(9):1750-1755.

  11. Shin E-J, Jeong JH, Chung YH, et al. Role of oxidative stress inepileptic seizures. Neurochem Int. 2011; 59(2):122-137.

  12. Kumar A, Lalitha S, Mishra J. Possible nitric oxide mechanismin the protective effect of hesperidin against pentylenetetrazole(PTZ)-induced kindling and associated cognitive dysfunction inmice. Epilepsy Behav. 2013; 29(1):103-111. doi:10.1016/j.yebeh.2013.06.007

  13. Saha L, Chakrabarti A. Understanding the anti-kindling roleand its mechanism of Resveratrol in Pentylenetetrazole inducedkindlingin a rat model. Pharmacol Biochem Behav. 2014;120:57-64. doi:10.1016/j.pbb.2014.01.010

  14. Kowski AB, Weissinger F, Gaus V, Fidzinski P, Losch F, HoltkampM. Specific adverse effects of antiepileptic drugs--A true-to-lifemonotherapy study. Epilepsy Behav. 2016; 54:150-157.doi:10.1016/j.yebeh.2015.11.009

  15. Pahuja M, Mehla J, Kumar Gupta Y. Anticonvulsant andantioxidative activity of hydroalcoholic extract of tuber ofOrchis mascula in pentylenetetrazole and maximal electroshockinduced seizures in rats. J Ethnopharmacol. 2012; 142(1):23-27. doi:10.1016/j.jep.2012.04.006

  16. Babar ZU, Ata A, Meshkatalsadat MH. New bioactive steroidalalkaloids from Buxus hyrcana. Steroids. 2006; 71(13-14):1045-1051. doi:10.1016/j.steroids.2006.09.002

  17. Choudhary MI, Shahnaz S, Parveen S, et al. New cholinesteraseinhibitingtriterpenoid alkaloids from Buxus hyrcana.Chem Biodivers. 2006;3(9):1039-1052. doi:10.1002/cbdv.200690102

  18. Esmaeili S, Naghibi F, Mosaddegh M, Sahranavard S, GhafariS, Abdullah NR. Screening of antiplasmodial properties amongsome traditionally used Iranian plants. J Ethnopharmacol.2009;121(3):400-404. doi:10.1016/j.jep.2008.10.041

  19. Ata A, Iverson CD, Kalhari KS, et al. Triterpenoidal alkaloids fromBuxus hyrcana and their enzyme inhibitory, anti-fungal and antileishmanialactivities. Phytochemistry. 2010; 71(14-15):1780-1786. doi:10.1016/j.phytochem.2010.06.017

  20. Ebrahimzadeh MA, Nabavi SM, Nabavi SF, Bahramian F,Bekhradnia AR. Antioxidant and free radical scavenging activityof H. officinalis L. var. angustifolius, V. odorata, B. hyrcana andC. speciosum. Pak J Pharm Sci. 2010; 23(1):29-34.

  21. Mesaik MA, Halim SA, Ul-Haq Z, et al. Immunosuppressiveactivity of buxidin and E-buxenone from Buxushyrcana. Chem Biol Drug Des. 2010; 75(3):310-317.doi:10.1111/j.1747-0285.2009.00906.x

  22. 22.Azizi V, Allahyari F, Hosseini A. The antiepileptic andneuroprotective effect of the Buxus hyrcana Pojark hydroethanolicextract against the pentylentetrazol induced model of the seizuresin the male rats. Int J Neurosci. 2018; 128(10):913-919. doi:10.1080/00207454.2018.1443925

  23. Pahuja M, Mehla J, Reeta KH, Tripathi M, Gupta YK. Effect ofAnacyclus pyrethrum on pentylenetetrazole-induced kindling,spatial memory, oxidative stress and rho-kinase II expression inmice. Neurochem Res. 2013; 38(3):547-556. doi:10.1007/s11064-012-0947-2

  24. Gomar A, Hosseini A, Mirazi N. Preventive effect of Rubusfruticosus on learning and memory impairment in an experimentalmodel of diabetic neuropathy in male rats. PharmaNutrition.2014;2(4):155-160.

  25. Beutler E, Duron O, Kelly BM. Improved method for thedetermination of blood glutathione. J Lab Clin Med.1963;61:882-888.

  26. Biswas D, Banerjee M, Sen G, et al. Mechanism of erythrocytedeath in human population exposed to arsenic throughdrinking water. Toxicol Appl Pharmacol. 2008; 230(1):57-66.doi:10.1016/j.taap.2008.02.003

  27. Schulz K, Kerber S, Kelm M. Reevaluation of the Griess methodfor determining NO/NO2- in aqueous and protein-containingsamples. Nitric Oxide Biol Chem. 1999; 3(3):225-234.doi:10.1006/niox.1999.0226

  28. Choudhary KM, Mishra A, Poroikov VV, Goel RK. Ameliorativeeffect of Curcumin on seizure severity, depression like behavior,learning and memory deficit in post-pentylenetetrazole-kindledmice. Eur J Pharmacol. 2013; 704(1-3):33-40.

  29. Mariani E, Polidori M, Cherubini A, Mecocci P. Oxidative stressin brain aging, neurodegenerative and vascular diseases: anoverview. J Chromatogr B. 2005; 827(1):65-75.

  30. Perry G, Nunomura A, Hirai K, et al. Is oxidative damage thefundamental pathogenic mechanism of Alzheimer’s and otherneurodegenerative diseases? Free Radic Biol Med. 2002;33(11):1475-1479.

  31. Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants inepilepsy. Clin Chim Acta. 2001; 303(1-2):19-24.

  32. Zhao R-r, Xu X-c, Xu F, et al. Metformin protects against seizures,learning and memory impairments and oxidative damageinduced by pentylenetetrazole-induced kindling in mice. BiochemBiophys Res Commun. 2014; 448(4):414-417.

  33. Rauca C, Zerbe R, Jantze H. Formation of free hydroxyl radicalsafter pentylenetetrazol-induced seizure and kindling. Brainresearch. 1999; 847(2):347-351.

  34. Nassiri-Asl M, Moghbelinejad S, Abbasi E, et al. Effects ofquercetin on oxidative stress and memory retrieval in kindledrats. Epilepsy Behav. 2013; 28(2):151-155.

  35. Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseasesand oxidative stress. Nat Rev Drug Discov. 2004; 3(3):205-214.doi:10.1038/nrd1330

  36. Stewart VC, Heales SJ. Nitric oxide-induced mitochondrialdysfunction: implications for neurodegeneration. FreeRadic Biol Med. 2003; 34(3):287-303. doi:10.1016/s0891-5849(02)01327-8

  37. Murashima YL, Yoshii M, Suzuki J. Ictogenesis andepileptogenesis in EL mice. Epilepsia. 2002; 43 Suppl 5:130-135. doi:10.1046/j.1528-1157.43.s.5.35.x

  38. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants:Determination of radical-scavenging efficiencies. Meth Enzymol.Vol 186: Elsevier; 1990:343-355.

  39. Ishige K, Schubert D, Sagara Y. Flavonoids protect neuronal cellsfrom oxidative stress by three distinct mechanisms. Free RadicBiol Med. 2001; 30(4):433-446.

  40. Cárdenas-Rodríguez N, Coballase-Urrutia E, Pérez-CruzC, et al. Relevance of the glutathione system in temporallobe epilepsy: evidence in human and experimental models.Oxid Med Cell Longev. 2014; 2014:759293-759293.doi:10.1155/2014/759293

  41. Wollenweber E, Rustaiyan A. Exudate flavonoids in three persianasteraceae species. Biochem Syst Ecol. 1991; 19(8):673-675.doi:10.1016/0305-1978(91)90084-D




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Neurocien. 2022;27

ARTíCULOS SIMILARES

CARGANDO ...